Signal integration at the PI3K-p85-XBP1 hub endows coagulation protease activated protein C with insulin-like function.
Signal integration at the PI3K-p85-XBP1 hub endows coagulation protease activated protein C with insulin-like function.
复制标题
DOI:
10.1182/blood-2017-02-767921
复制
发表时间:
2017-09-21
期刊:
影响因子:
20.3
通讯作者:
Isermann B
中科院分区:
文献类型:
--
作者:
Madhusudhan T;Wang H;Ghosh S;Dong W;Kumar V;Al-Dabet MM;Manoharan J;Nazir S;Elwakiel A;Bock F;Kohli S;Marquardt A;Sögüt I;Shahzad K;Müller AJ;Esmon CT;Nawroth PP;Reiser J;Chavakis T;Ruf W;Isermann B
Coagulation proteases have increasingly recognized functions beyond hemostasis and thrombosis. Disruption of activated protein C (aPC) or insulin signaling both impair function of podocytes and ultimately cause dysfunction of the glomerular filtration barrier and diabetic kidney disease (DKD). We here show that insulin and aPC converge on a common spliced-X-box binding protein-1 (sXBP1) signaling pathway to maintain endoplasmic reticulum (ER)-homeostasis. Analogous to insulin, physiological levels of aPC maintain endoplasmic reticulum (ER) proteostasis in DKD. Accordingly, genetically impaired protein C activation exacerbates maladaptive ER-response, while genetic or pharmacological restoration of aPC maintains ER-proteostasis in DKD models. Importantly, in mice with podocyte specific deficiency of insulin receptor (INSR), aPC selectively restores the activity of the cytoprotective ER-transcription factor sXBP1 by temporally targeting INSR downstream signaling intermediates, the regulatory subunits of PI3Kinase, p85α and p85β. Genome-wide mapping of condition-specific XBP1-transcriptional regulatory patterns confirmed that concordant UPR target genes are involved in maintenance of ER-proteostasis by both insulin and aPC. Thus, aPC efficiently employs disengaged insulin signaling components to re-configure ER-signaling and restore proteostasis. These results identify ER-reprogramming as a novel hormone-like function of coagulation proteases and demonstrate that targeting insulin signaling intermediates may be a feasible therapeutic approach ameliorating defective insulin signaling.
登录
查看更多内容
DOI:
10.1016/j.bbrc.2016.10.106
发表时间:
2016-11-25
影响因子:
3.1
作者:
Nam, Dae-Hwan;Han, Jung-Hwa;Woo, Chang-Hoon
通讯作者:
Woo, Chang-Hoon
影响因子:
48
作者:
Pepke, Shirley;Wold, Barbara;Mortazavi, Ali
通讯作者:
Mortazavi, Ali
DOI:
10.1083/jcb.201003138
发表时间:
2010-05-31
期刊:
The Journal of cell biology
影响因子:
--
作者:
Rutkowski DT;Hegde RS
通讯作者:
Hegde RS
影响因子:
56.9
作者:
Hetz, C;Bernasconi, P;Korsmeyer, SJ
通讯作者:
Korsmeyer, SJ
影响因子:
16
作者:
Acosta-Alvear, Diego;Zhou, Yiming;Dynlacht, Brian David
通讯作者:
Dynlacht, Brian David